Riddell S R, Rabin M, Geballe A P, Britt W J, Greenberg P D
Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
J Immunol. 1991 Apr 15;146(8):2795-804.
The human pathogen CMV, is a major cause of morbidity and mortality in immunocompromised hosts. The CD8+ class I-restricted CTL response to CMV assists in preventing progression of CMV infection to life-threatening disease; however, the viral Ag recognized by CD8+ CTL are not well characterized. In general, virus-specific CTL recognize endogenously synthesized viral proteins processed and presented associated with class I MHC molecules. Although proteins or inactivated virions have been experimentally delivered to the cytoplasm to result in class I MHC presentation, this mode of Ag delivery to the class I processing pathway after natural viral entry has not been documented in humans. Our data demonstrate that the CMV-specific class I-restricted CTL response in individuals latently infected with CMV is predominantly specific for selected structural virion proteins introduced into the cell after viral penetration and efficient recognition occurs in the absence of de novo viral gene expression. This CTL response may provide a biological advantage for limiting the spread of infection after CMV reactivation because infected cells are lysed before viral assembly.
人类病原体巨细胞病毒(CMV)是免疫功能低下宿主发病和死亡的主要原因。CD8⁺ I类限制性细胞毒性T淋巴细胞(CTL)对CMV的反应有助于防止CMV感染发展为危及生命的疾病;然而,CD8⁺ CTL识别的病毒抗原尚未得到很好的表征。一般来说,病毒特异性CTL识别与I类主要组织相容性复合体(MHC)分子相关的内源性合成、加工和呈递的病毒蛋白。尽管蛋白质或灭活病毒粒子已通过实验递送至细胞质以导致I类MHC呈递,但在自然病毒进入后,这种抗原递送至I类加工途径的方式在人类中尚未得到记录。我们的数据表明,在潜伏感染CMV的个体中,CMV特异性I类限制性CTL反应主要针对病毒穿透后引入细胞的选定结构病毒粒子蛋白,并且在没有病毒基因从头表达的情况下发生有效识别。这种CTL反应可能为限制CMV重新激活后感染的传播提供生物学优势,因为感染的细胞在病毒组装之前就被裂解了。